FDA Inspection 1098272 — Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Gedian Humanwell Pharmaceutical Co., Ltd. on June 28, 2019 in Ezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 28, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)